David L. Mayhew

Biochemistry, Genetics and Molecular BiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 4 papers. Top paper: “VRK1 as a synthetic lethal target in VRK2 promoter–methylated cancers of the nervous system”.

VRK1 as a synthetic lethal target in VRK2 promoter–methylated cancers of the nervous system

JCI Insight(2022)10.1172/jci.insight.158755

N/A

0.612DataRank · unranked

58 citations

Nathaniel W. Mabe, Bernhard Englinger, Kin-Hoe Chow, Sydney M. Moyer, Smitha Yerrum +17 more

RAF1 amplification drives a subset of bladder tumors and confers sensitivity to MAPK-directed therapeutics

Journal of Clinical Investigation(2021)10.1172/jci147849

N/A

0.533DataRank · unranked

34 citations

Amruta S. Samant, Amin H. Nassar, Jonathan So, Elizabeth P. Garcia, Catherine R. Curran +13 more

Genomic Amplification and Functional Dependency of the Gamma Actin Gene ACTG1 in Uterine Cancer

International Journal of Molecular Sciences(2020)10.3390/ijms21228690

N/A

0.520DataRank · unranked

31 citations

David L. Mayhew, Jonathan Rennhack, Jonathan So, Elizabeth H. Stover, Justin H. Hwang +2 more

VRK1 is required in VRK2-methylated cancers of the nervous system

bioRxiv (Cold Spring Harbor Laboratory)(2021)10.1101/2021.12.28.474386

N/A

0DataRank · unranked

4 citations

Nathaniel W. Mabe, Bernhard Englinger, Sydney M. Moyer, Maria Trissal, Joana G. Marques +10 more